Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer
Christine Maheu(University Health Network), Souraya Sidani(York University), Cheryl Harris(University of Ottawa), Aronela Benea(Women's College Hospital), Lynne Jolicoeur(Ottawa Hospital), Agnihotram V. Ramanakumar(McGill University Health Centre), Sarah E. Ferguson(University Health Network), Linda Muraca(Mount Sinai Hospital), Monique Lefèbvre(Ottawa Hospital), Christine Courbasson, Lori J. Bernstein(St. Michael's Hospital), Mina Singh(York University), Sophie Lebel(University of Ottawa)
Cited by 59
Related Papers
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta‐analysis
|Psycho-Oncology|2022|295
Sleep disturbance in adults with cancer: a systematic review of evidence for best practices in assessment and management for clinical practice
|Annals of Oncology|2013|250
Psychometric Properties of the Tampa Scale for Kinesiophobia-11 (TSK-11)
|Journal of Pain|2012|229